| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Departments of 2 Nutrition and 3 Epidemiology, Harvard School of Public Health; 4 Harvard Center for Cancer Prevention; 5 Epidemiology Program, Dana-Faber/Harvard Cancer Center; and 6 Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts and 7 Ludwig Boltzmann-Institute for Applied Cancer Research, KFJ-Spital, Vienna, Austria
Requests for reprints: Eva S. Schernhammer, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115. Phone: 617-525-4648; Fax: 617-525-2008. E-mail: eva.schernhammer{at}channing.harvard.edu
Background: A history of diabetes mellitus and a diet high in glycemic load are both potential risk factors for pancreatic cancer. Sugar-sweetened soft drinks are a prevalent source of readily absorbable sugars and have been associated with an increased risk of obesity and diabetes. We investigated whether higher consumption of sugar-sweetened soft drinks increases the risk of pancreatic cancer.
Methods: We examined the relation between consumption of sugar-sweetened soft drinks and the development of pancreatic cancer in the Nurses' Health Study and the Health Professionals Follow-up Study. Among 88,794 women and 49,364 men without cancer at baseline, we documented 379 cases of pancreatic cancer during up to 20 years of follow-up. Soft drink consumption was first assessed at baseline (1980 for the women, 1986 for the men) and updated periodically thereafter.
Results: Compared with participants who largely abstained from sugar-sweetened soft drinks, those who consumed more than three sugar-sweetened soft drinks weekly experienced overall a multivariate relative risk (RR) of pancreatic cancer of 1.13 [95% confidence interval (95% CI), 0.81-1.58; P for trend = 0.47]. Women in the highest category of sugar-sweetened soft drink intake did experience a significant increase in risk (RR, 1.57; 95% CI, 1.02-2.41; P for trend = 0.05), whereas there was no association between sweetened soft drink intake and pancreatic cancer among men. Among women, the risk associated with higher sugar-sweetened soft drink was limited to those with elevated body mass index (>25 kg/m2; RR, 1.89; 95% CI, 0.96-3.72) or with low physical activity (RR, 2.02; 95% CI, 1.06-3.85). In contrast, consumption of diet soft drinks was not associated with an elevated pancreatic cancer risk in either cohort.
Conclusion: Although soft drink consumption did not influence pancreatic cancer risk among men, consumption of sugar-sweetened soft drinks may be associated with a modest but significant increase in risk among women who have an underlying degree of insulin resistance.
This article has been cited by other articles:
![]() |
M. M Heinen, B. A. Verhage, L. Lumey, H. A. Brants, R A. Goldbohm, and P. A van den Brandt Glycemic load, glycemic index, and pancreatic cancer risk in the Netherlands Cohort Study Am. J. Clinical Nutrition, April 1, 2008; 87(4): 970 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Nothlings, S. P Murphy, L. R Wilkens, B. E Henderson, and L. N Kolonel Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Larsson, L. Bergkvist, and A. Wolk Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1171 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S Malik, M. B Schulze, and F. B Hu Intake of sugar-sweetened beverages and weight gain: a systematic review. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 274 - 288. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |